Core Insights - Over a quarter of American adults with diabetes used GLP-1 injection drugs last year, indicating a significant adoption of these medications for managing type 2 diabetes and weight loss [4] - The most common age group using these drugs is 50 to 64 years old, with a usage rate of 33.3%, reflecting a higher disease burden in this demographic [4] - The high cost of GLP-1 drugs, approximately $1,000 per month, has drawn criticism despite their effectiveness [6] Usage Statistics - Approximately 31% of insulin users also use GLP-1 drugs, while about 28% of oral hypoglycemic drug users do the same, suggesting GLP-1 therapy is increasingly integrated into combination treatment plans [6] - Among different ethnic groups, Hispanic diabetic adults have the highest usage rate of GLP-1 drugs at 31.3%, followed by non-Hispanic Black at 26.5% and non-Hispanic White at 26.2%. Non-Hispanic Asian adults have the lowest usage rate at 12.1% [6] Drug Mechanism - GLP-1 drugs mimic the action of hormones that regulate blood sugar levels, delay digestion, and prolong feelings of fullness, contributing to blood sugar control and weight loss [6][15]

Core Viewpoint - The article highlights the increasing usage of GLP-1 medications among diabetes patients in the U.S., indicating a significant trend in diabetes management and weight loss treatment [2][4]. Group 1: Usage Statistics - Over 25% of U.S. adults with diabetes used GLP-1 injection medications last year, with the highest usage among those aged 50 to 64 at 33.3% [2]. - The usage rate for the 18 to 34 age group is 25.3%, while for those aged 65 and above, it is 20.8% [2]. - Approximately 31% of insulin users also use GLP-1 medications, and about 28% of oral hypoglycemic drug users are incorporating GLP-1 into their treatment regimens [4]. Group 2: Demographic Insights - Among different ethnic groups, Hispanic diabetes adults have the highest GLP-1 usage rate at 31.3%, followed by non-Hispanic Black at 26.5% and non-Hispanic White at 26.2% [4]. - Non-Hispanic Asian individuals have the lowest usage rate at 12.1%, which may be attributed to differences in treatment accessibility or acceptance [4]. Group 3: Mechanism and Pricing - GLP-1 medications mimic the action of hormones that regulate blood sugar levels, delay digestion, and prolong feelings of fullness [4]. - The high cost of these medications, approximately $1,000 per month, has drawn criticism [4].